Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Whats obvious to me is that TPL knows what they have

I think one can easily conclude from the filings, that the J's combined gave us in the neighborhood of $21M. When you take into account the other companies that were signed and reported in that 10q, and their sizes, and alot a sensible amount of money to each based on previous history of licenses, you'll see about $21M is left over. So, based on that, I think it's logical to attribute that $21M to the J's signings. So to say the J's gave us nothing, is incorrect IMO. Ceratinly it was less than we were expecting but $21M or there abouts is better than nothing.

Similarly, I'd suspect that Asustek got off cheap to sign and allow the legal haranguing to go on elsewhere. Based on a $6.9B annual revenue, Asustek could have brought in around $2.69M in MMP licensing based on the average of the other 51 or so licenses, so it likely ultimately brought in a bit less, IMO. Still $2.69M is better than nothing while the USPTO decision is still pending.

Share
New Message
Please login to post a reply